Statistics from Altmetric.com
Increasing use of non-invasive ventilation has led to the development of techniques which deliver surfactant without resort to intubation. These are called less invasive surfactant administration (LISA) or minimally invasive surfactant therapy (MIST). A systematic review of six randomised controlled trials demonstrated LISA use in infants with respiratory distress syndrome was associated with a reduced incidence of bronchopulmonary dysplasia and death at 36 weeks and need for mechanical ventilation1; the latter was also reported in a further systematic review.2 A survey of LISA use across Europe demonstrated variation in practice.3 Only 12 UK units, however, were included hence we determined current practice regarding LISA in all levels of UK neonatal units. An online questionnaire was sent to all …
Contributors AG, EJ and KH designed the study. EJ and KH undertook the survey, EJ and KH undertook the analysis. EJ wrote the first draft and all authors produced the final manuscript.
Funding This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas' NHS Foundation Trust and King’s College London.
Disclaimer The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Data sharing statement We are happy to share data on request.
Patient consent for publication Not required.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.